よむ、つかう、まなぶ。
【参考資料２－１】抗微生物薬適正使用の手引き 第四版（案）医科・外来編 (20 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_64503.html |
| 出典情報 | 厚生科学審議会 感染症部会（第99回 10／21）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
抗微生物薬適正使用の手引き
第四版
医科・外来編
17. National Action Plan to Prevent Health Care-Associated Infections: Road Map to Elimination
Phase Four: Coordination among Federal Partners to Leverage HAI Prevention and
Antibiotic Stewardship, February 5th, 2018. https://health.gov/sites/default/files/201909/National_Action_Plan_to_Prevent_HAIs_Phase_IV_2018.pdf. 最終閲覧日 2023 年 6 月 19
日.
18. Evans L, et al. Surviving Sepsis Campaign: International Guidelines for Management of
Sepsis and Septic Shock 2021. Crit Care Med. 2021. 49(11):e1063-e1143
19. Poutsiaka DD, et al. Risk factors for death after sepsis in patients immunosuppressed before
the onset of sepsis. Scand J Infect Dis. 2009. 41(6-7):469-479.
20. Barlam TF, et al. Implementing an Antibiotic Stewardship Program: Guidelines by the
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of
America. Clin Infect Dis. 2016. 62(10):e51-77.
21. Arnold SR, et al. Interventions to improve antibiotic prescribing practices in ambulatory care.
Cochrane Database Syst Rev. 2005. 2005(4):CD003539.
22. Sharland M, Pulcini C, Harbarth S, et al. Classifying antibiotics in the WHO Essential
Medicines List for optimal use—be AWaRe. The Lancet Infectious Diseases. 2018;18:18-20.
23. World Health Organization. The selection and use of essential medicines 2023: report of the
23rd WHO Expert Committee. Geneva: World Health Organization; 2023.
20
第四版
医科・外来編
17. National Action Plan to Prevent Health Care-Associated Infections: Road Map to Elimination
Phase Four: Coordination among Federal Partners to Leverage HAI Prevention and
Antibiotic Stewardship, February 5th, 2018. https://health.gov/sites/default/files/201909/National_Action_Plan_to_Prevent_HAIs_Phase_IV_2018.pdf. 最終閲覧日 2023 年 6 月 19
日.
18. Evans L, et al. Surviving Sepsis Campaign: International Guidelines for Management of
Sepsis and Septic Shock 2021. Crit Care Med. 2021. 49(11):e1063-e1143
19. Poutsiaka DD, et al. Risk factors for death after sepsis in patients immunosuppressed before
the onset of sepsis. Scand J Infect Dis. 2009. 41(6-7):469-479.
20. Barlam TF, et al. Implementing an Antibiotic Stewardship Program: Guidelines by the
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of
America. Clin Infect Dis. 2016. 62(10):e51-77.
21. Arnold SR, et al. Interventions to improve antibiotic prescribing practices in ambulatory care.
Cochrane Database Syst Rev. 2005. 2005(4):CD003539.
22. Sharland M, Pulcini C, Harbarth S, et al. Classifying antibiotics in the WHO Essential
Medicines List for optimal use—be AWaRe. The Lancet Infectious Diseases. 2018;18:18-20.
23. World Health Organization. The selection and use of essential medicines 2023: report of the
23rd WHO Expert Committee. Geneva: World Health Organization; 2023.
20